Anika Reports First Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Anika Therapeutics (ANIK) Tops Q1 EPS by 12c; $50M Buyback
May 2, 2019 4:43 PM EDTAnika Therapeutics (NASDAQ: ANIK) reported Q1 EPS of $0.31, $0.12 better than the analyst estimate of $0.19. Revenue for the quarter came in at $24.7 million versus the consensus estimate of $21.88 million.
Announces $50 Million Share Repurchase Program.
Anika is off to a strong start in 2019, with double-digit... More



